Zevra Therapeutics Files 8-K on Financials
Ticker: ZVRA · Form: 8-K · Filed: Mar 11, 2025 · CIK: 1434647
| Field | Detail |
|---|---|
| Company | Zevra Therapeutics, Inc. (ZVRA) |
| Form Type | 8-K |
| Filed Date | Mar 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: ZVRA
TL;DR
Zevra Therapeutics dropped an 8-K on March 11th detailing their financial condition - check it for the latest numbers.
AI Summary
Zevra Therapeutics, Inc. filed an 8-K on March 11, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report period and filing date both being March 11, 2025. The company, formerly known as KemPharm, Inc., is incorporated in Delaware and headquartered in Celebration, Florida.
Why It Matters
This 8-K filing provides an update on Zevra Therapeutics' financial condition and operational results, which is crucial information for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or adverse events.
Key Players & Entities
- ZEVRA THERAPEUTICS, INC. (company) — Registrant
- KEMPHARM, INC (company) — Former company name
- March 11, 2025 (date) — Filing date and report date
- Delaware (jurisdiction) — State of incorporation
- Celebration, FL (location) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed and what period does it cover?
The report was filed on March 11, 2025, and the period of the report is also March 11, 2025.
What is Zevra Therapeutics, Inc.'s former company name?
Zevra Therapeutics, Inc. was formerly known as KEMPHARM, INC.
Where are Zevra Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 1180 Celebration Boulevard, Suite 103, Celebration, FL 34747.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 11, 2025 regarding ZEVRA THERAPEUTICS, INC. (ZVRA).